Edition:
United States

GlaxoSmithKline PLC (GSK)

GSK on New York Consolidated

38.20USD
19 Jan 2018
Change (% chg)

$0.03 (+0.08%)
Prev Close
$38.17
Open
$38.14
Day's High
$38.32
Day's Low
$37.98
Volume
3,478,233
Avg. Vol
5,091,678
52-wk High
$44.53
52-wk Low
$34.52

Latest Key Developments (Source: Significant Developments)

GSK Receives FDA Approval For Expanded Indication For Fluarix
Friday, 12 Jan 2018 08:00am EST 

Jan 12 (Reuters) - Glaxosmithkline Plc ::GSK RECEIVES FDA APPROVAL FOR EXPANDED INDICATION FOR FLUARIX® QUADRIVALENT (INFLUENZA VACCINE) FOR PERSONS 6 MONTHS AND OLDER.  Full Article

GSK CEO Says No Expected Dividend Increase In Near Term
Tuesday, 9 Jan 2018 02:07pm EST 

Jan 9 (Reuters) - Glaxosmithkline Plc ::GSK CEO SAYS WILL TAKE TIME TO BUILD REIMBURSEMENT FOR SHINGRIX SHINGLES VACCINE.GSK CEO SAYS HAS NO DOUBT SHINGRIX CAN BE COMPANY'S MOST LUCRATIVE VACCINE.GSK CEO SAYS NO CHANGE TO DIVIDEND POLICY LAID OUT LAST YEAR.GSK CEO SAYS NO EXPECTED DIVIDEND INCREASE IN NEAR TERM.GSK CEO SAYS HAVING A LOOK AT PFIZER CONSUMER BUSINESS; WE DON'T NEED IT, WOULDN'T OVERPAY FOR IT.  Full Article

GlaxoSmithkLine Acquires Further 26 Pct Stake In Glaxo Saudi Arabia
Monday, 18 Dec 2017 04:19am EST 

Dec 18 (Reuters) - GLAXOSMITHKLINE ::ACQUIRES ADDITIONAL 26 PERCENT STAKE IN GLAXO SAUDI ARABIA LIMITED‍​.INTENDS TO EXPAND PRODUCTION OF JEDDAH MANUFACTURE SITE BY 30 PERCENT IN NEXT 3 YEARS WITH MORE INVESTMENTS TO BE DONE BY 2020‍​.SAYS "ACQUISITION IS COMING ON TOP OF MORE THAN SAR 900 MILLION THAT GSK IS INVESTING IN ITS OPERATION IN SAUDI OVER NEXT 3 YEARS‍​".SAYS "BY INCREASING STAKE IN GSAL, GSK REITERATES COMMITMENT TO SUPPORT SAUDI GOVERNMENT PLANS TO DIVERSIFY ECONOMY ‍".  Full Article

Glaxosmithkline Submits Regulatory Application For Single-Dose Tafenoquine For Treatment Of Plasmodium Vivax Malaria
Thursday, 14 Dec 2017 12:14am EST 

Dec 14 (Reuters) - Glaxosmithkline Plc ::SUBMITS REGULATORY APPLICATION FOR SINGLE-DOSE TAFENOQUINE FOR TREATMENT OF PLASMODIUM VIVAX MALARIA TO AUSTRALIA'S THERAPEUTIC GOODS ADMINISTRATION​.GSK PLANS TO PROGRESS REGULATORY FILINGS IN OTHER COUNTRIES IN 2018‍​.  Full Article

U.S. FDA Approves First Drug For Eosinophilic Granulomatosis With Polyangiitis
Tuesday, 12 Dec 2017 10:27am EST 

Dec 12 (Reuters) - U.S. Food and Drug Administration::SAYS EXPANDED APPROVED USE OF NUCALA (MEPOLIZUMAB) TO TREAT ADULT PATIENTS WITH EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS‍.SAYS GRANTED APPROVAL OF NUCALA TO GLAXOSMITHKLINE.  Full Article

Glaxosmithkline Says ‍New Data From Phase III Clinical Study Supports Safety And Efficacy
Wednesday, 6 Dec 2017 02:00am EST 

Dec 6 (Reuters) - Glaxosmithkline Plc ::‍NEW DATA FROM A PHASE III CLINICAL STUDY SUPPORTS SAFETY AND EFFICACY OF SHINGRIX IN PREVENTING SHINGLES​.ZOE-HSCT STUDY SUCCEEDED PRIMARY OBJECTIVE BY DEMONSTRATING AN EFFICACY OF 68.17% AGAINST SHINGLES IN SUBJECTS ABOVE 18 YEARS OF AGE​.  Full Article

ACCC Institutes Proceedings Against GSK, Novartis
Tuesday, 5 Dec 2017 05:39pm EST 

Dec 6 (Reuters) - Australian Competition and Consumer Commission:INSTITUTED PROCEEDINGS AGAINST GLAXOSMITHKLINE HEALTHCARE AUSTRALIA PTY LTD (GSK) AND NOVARTIS CONSUMER HEALTH AUSTRALASIA.PROCEEDINGS ALLEGING THEY MADE FALSE OR MISLEADING REPRESENTATIONS IN MARKETING OF VOLTAREN OSTEO GEL AND VOLTAREN EMULGEL PAIN RELIEF PRODUCTS.SEEKING DECLARATIONS, INJUNCTIONS, PECUNIARY PENALTIES, A PUBLICATION ORDER, THE IMPOSITION OF A COMPLIANCE PROGRAM AND COSTS.  Full Article

John Wood Group Wins Multi-Million Dollar Contract Supporting Glaxosmithkline In Germany​
Tuesday, 5 Dec 2017 02:00am EST 

Dec 5 (Reuters) - John Wood Group Plc ::WOOD WINS CONTRACT SUPPORTING GLAXOSMITHKLINE.‍WOOD WINS MULTI-MILLION DOLLAR CONTRACT SUPPORTING GLAXOSMITHKLINE IN GERMANY​.  Full Article

Glaxosmithkline says ViiV Healthcare starts Phase 3 HIV prevention study in women
Thursday, 30 Nov 2017 02:05am EST 

Nov 30 (Reuters) - GLAXOSMITHKLINE PLC ::‍VIIV STARTS PHASE 3 HIV PREVENTION STUDY IN WOMEN​.‍VIIV HEALTHCARE, CO OWNED BY GSK, WITH PFIZER INC. AND SHIONOGI LTD AS SHAREHOLDERS, TO START PHASE III STUDY FOR PREVENTION OF HIV INFECTION IN SEXUALLY ACTIVE WOMEN​.  Full Article

GSK says submits US application for malaria drug
Monday, 27 Nov 2017 11:02pm EST 

Nov 28 (Reuters) - GLAXOSMITHKLINE PLC ::‍SUBMITS US REGULATORY APPLICATION FOR SINGLE-DOSE TAFENOQUINE FOR PLASMODIUM VIVAX MALARIA​.GSK.L - ‍TAFENOQUINE IS NOT APPROVED FOR USE ANYWHERE IN WORLD; PLANS TO PROGRESS REGULATORY FILINGS IN OTHER COUNTRIES IN 2017 AND 2018​.  Full Article

BRIEF-GSK Receives FDA Approval For Expanded Indication For Fluarix

* GSK RECEIVES FDA APPROVAL FOR EXPANDED INDICATION FOR FLUARIX® QUADRIVALENT (INFLUENZA VACCINE) FOR PERSONS 6 MONTHS AND OLDER Source text for Eikon: Further company coverage: